ambroxol has been researched along with Neuralgia in 4 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ambroxol is a multifaceted drug with primarily mucoactive and secretolytic actions, along with anti-inflammatory, antioxidant, and local anaesthetic properties." | 3.01 | Ambroxol for neuropathic pain: hiding in plain sight? ( Baron, R; Dickenson, AH; Kern, KU; Russo, MA; Santarelli, DM, 2023) |
| "Ambroxol acts as a strong local anaesthetic and preferentially inhibits the nociceptively relevant sodium channel subtype Nav 1." | 1.42 | Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation. ( Kern, KU; Weiser, T, 2015) |
| "Ambroxol acts as a strong local anesthetic and preferentially inhibits the nociceptive-relevant sodium channel subtype Nav 1." | 1.42 | [Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version]. ( Kern, KU; Weiser, T, 2015) |
| "Ambroxol was tested in rats that underwent a mid-thoracic spinal cord compression injury." | 1.36 | Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain. ( Hama, AT; Plum, AW; Sagen, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russo, MA | 1 |
| Baron, R | 1 |
| Dickenson, AH | 1 |
| Kern, KU | 3 |
| Santarelli, DM | 1 |
| Weiser, T | 2 |
| Hama, AT | 1 |
| Plum, AW | 1 |
| Sagen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy[NCT05558878] | 80 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ambroxol and Neuralgia
| Article | Year |
|---|---|
Ambroxol for neuropathic pain: hiding in plain sight?
Topics: Ambroxol; Analgesics; Anesthetics, Local; Humans; Neuralgia; Pain Measurement | 2023 |
3 other studies available for ambroxol and Neuralgia
| Article | Year |
|---|---|
Topical ambroxol for the treatment of neuropathic pain. An initial clinical observation.
Topics: Administration, Topical; Adult; Aged; Ambroxol; Amines; Anesthetics, Local; Cyclohexanecarboxylic Ac | 2015 |
[Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version].
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Ambroxol; Capsaicin; Female; Humans; Lidoca | 2015 |
Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain.
Topics: Ambroxol; Analgesics; Animals; Behavior, Animal; Hot Temperature; Hyperalgesia; Injections, Spinal; | 2010 |